CASSANDRA RULLMAN: Open Payments
NPI 1649746801 · CHEVY CHASE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$258 in 10 payments from 6 companies in 2025. Trend: 2023 $554 · 2024 $706 · 2025 $258
Food & beverage: $258
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $94 |
| Lilly USA, LLC | 2 | $52 |
| GENZYME CORPORATION | 1 | $39 |
| Regeneron Healthcare Solutions, Inc. | 1 | $32 |
| Incyte Corporation | 1 | $25 |
| Amgen Inc. | 1 | $17 |
Products named: SKYRIZI, EBGLYSS, DUPIXENT, LIBTAYO, OPZELURA, Otezla.
Industry payments across MD — which companies pay providers there.
